Cannabidiol attenuates aggressive behavior induced by social isolation in mice: Involvement of 5-HT1A and CB1 receptors.


Journal

Progress in neuro-psychopharmacology & biological psychiatry
ISSN: 1878-4216
Titre abrégé: Prog Neuropsychopharmacol Biol Psychiatry
Pays: England
ID NLM: 8211617

Informations de publication

Date de publication:
30 08 2019
Historique:
received: 24 10 2018
revised: 11 04 2019
accepted: 30 04 2019
pubmed: 6 5 2019
medline: 31 3 2020
entrez: 6 5 2019
Statut: ppublish

Résumé

Long-term single housing increases aggressive behavior in mice, a condition named isolation-induced aggression or territorial aggression, which can be attenuated by anxiolytic, antidepressant, and antipsychotic drugs. Preclinical and clinical findings indicate that cannabidiol (CBD), a non-psychotomimetic compound from Cannabis sativa, has anxiolytic, antidepressant, and antipsychotic properties. Few studies, however, have investigated the effects of CBD on aggressive behaviors. Here, we investigated whether CBD (5, 15, 30, and 60 mg/kg; i.p.) could attenuate social isolation-induced aggressive behavior in the resident-intruder test. Male Swiss mice (7-8 weeks) were single-housed for 10 days (resident mice) to induce aggressive behaviors, while conspecific mice of same sex and age (intruder mice) were group-housed. During the test, the intruder was placed into the resident's home-cage and aggressive behaviors initiated by the resident, including the latency for the first attack, number of attacks, and total duration of aggressive encounters, were recorded. The involvement of 5-HT1A and CB1 receptors (CB1R) in the effects of CBD was also investigated. All tested CBD doses induced anti-aggressive effects, indicated by a decrease in the number of attacks. CBD, at intermediary doses (15 and 30 mg/kg), also increased latency to attack the intruder and decreased the duration of aggressive encounters. No CBD dose interfered with locomotor behavior. CBD anti-aggressive effects were attenuated by the 5-HT1A receptor antagonist WAY100635 (0.3 mg/kg) and the CB1 antagonist AM251 (1 mg/kg), suggesting that CBD decreases social isolation-induced aggressive behaviors through a mechanism associated with the activation of 5-HT1A and CB1 receptors. Also, CBD decreased c-Fos protein expression, a neuronal activity marker, in the lateral periaqueductal gray (lPAG) in social-isolated mice exposed to the resident-intruder test, indicating a potential involvement of this brain region in the drug effects. Taken together, our findings suggest that CBD may be therapeutically useful to treat aggressive behaviors that are usually associated with psychiatric disorders.

Identifiants

pubmed: 31054943
pii: S0278-5846(18)30834-0
doi: 10.1016/j.pnpbp.2019.109637
pii:
doi:

Substances chimiques

Cannabinoid Receptor Antagonists 0
Piperazines 0
Piperidines 0
Proto-Oncogene Proteins c-fos 0
Pyrazoles 0
Pyridines 0
Receptor, Cannabinoid, CB1 0
Serotonin 5-HT1 Receptor Antagonists 0
Receptor, Serotonin, 5-HT1A 112692-38-3
Cannabidiol 19GBJ60SN5
AM 251 3I4FA44MAI
N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide 71IH826FEG

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

109637

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Alice Hartmann (A)

Department of Pharmacology, Medical School of Ribeirão Preto - University of São Paulo (FMRP-USP), 14049-900 Ribeirão Preto, São Paulo, Brazil; Center for Interdisciplinary Research on Applied Neurosciences (NAPNA), University of São Paulo (USP), Brazil.

Sabrina Francesca Lisboa (SF)

Department of Pharmacology, Medical School of Ribeirão Preto - University of São Paulo (FMRP-USP), 14049-900 Ribeirão Preto, São Paulo, Brazil; Center for Interdisciplinary Research on Applied Neurosciences (NAPNA), University of São Paulo (USP), Brazil. Electronic address: sabrinalisboa@usp.br.

Andreza Buzolin Sonego (AB)

Department of Pharmacology, Medical School of Ribeirão Preto - University of São Paulo (FMRP-USP), 14049-900 Ribeirão Preto, São Paulo, Brazil; Center for Interdisciplinary Research on Applied Neurosciences (NAPNA), University of São Paulo (USP), Brazil.

Débora Coutinho (D)

Department of Pharmacology, Medical School of Ribeirão Preto - University of São Paulo (FMRP-USP), 14049-900 Ribeirão Preto, São Paulo, Brazil.

Felipe Villela Gomes (FV)

Department of Pharmacology, Medical School of Ribeirão Preto - University of São Paulo (FMRP-USP), 14049-900 Ribeirão Preto, São Paulo, Brazil; Center for Interdisciplinary Research on Applied Neurosciences (NAPNA), University of São Paulo (USP), Brazil.

Francisco Silveira Guimarães (FS)

Department of Pharmacology, Medical School of Ribeirão Preto - University of São Paulo (FMRP-USP), 14049-900 Ribeirão Preto, São Paulo, Brazil; Center for Interdisciplinary Research on Applied Neurosciences (NAPNA), University of São Paulo (USP), Brazil.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH